Editorial: Stop thinking and start acting: Early Impella placement associated with improved outcomes, again!

about

Editorial: Stop thinking and start acting: Early Impella placement associated with improved outcomes, again!

Item

http://www.wikidata.org/entity/Q48202373

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Editorial: Stop thinking and s ...... with improved outcomes, again!

@en

Editorial: Stop thinking and s ...... with improved outcomes, again!

@nl

type

Item

label

Editorial: Stop thinking and s ...... with improved outcomes, again!

@en

Editorial: Stop thinking and s ...... with improved outcomes, again!

@nl

prefLabel

Editorial: Stop thinking and s ...... with improved outcomes, again!

@en

Editorial: Stop thinking and s ...... with improved outcomes, again!

@nl

P1476

Editorial: Stop thinking and s ...... with improved outcomes, again!

@en

P2093

Perwaiz M Meraj

http://www.w3.org/2001/XMLSchema#string

Rajkumar Doshi

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock.

The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.

Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.

Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival.

Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock

P304

584-585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/JOIC.12434

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rajkumar Doshi

Perwaiz M Meraj

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29193318

http://www.w3.org/2001/XMLSchema#string